Biotech Readout
Subscribe
Sign in
Home
Frontiers
History
Acquisitions
Weekly
Archive
About
Latest
Top
Discussions
BioMarin to Acquire Alesta
Rare disease maven bets on a next generation bone-forming medicine
Aug 18
•
Céline
1
Biotechs post wins in menopause hot flashes, anxiety disorder, polycythemia vera, and more
Weekly Readout #18: Week ending August 14, 2026
Aug 14
•
Céline
1
1
Jazz to Acquire Actio
How David Goldstein's precision neuroscience thesis hit escape velocity
Aug 10
•
Céline
1
AstraZeneca-BMS Merger Cancelled
Exploring the Pax Pharmaceutica that never arrived
Aug 8
•
Céline
1
1
1
Surprise approvals of Replimune's RP1 & Moderna's flu vaccine, orexin unlocks narcolepsy, and more
Weekly Readout #17: Week ending August 7, 2026
Aug 7
•
Céline
1
Hepatitis C, Part 2
How Pharmasset teamed up with Gilead and bested big pharma in the race for a cure
Aug 1
•
Céline
1
2
1
July 2026
Obesity drug treats alcoholism, a China-originated drug pursues $30 billion market, and more
Weekly Readout #16: Week ending July 31, 2026
Jul 31
•
Céline
1
1
Argenx to Acquire Forte Biosciences
How Paul Wagner's pivot from microbiome medicines to CD122 for celiac and vitiligo paid off
Jul 27
•
Céline
1
GSK-Nuvalent buyout bears fruit, diabetic obesity drug raises the bar, and more
Weekly Readout #15: Week ending July 24, 2026
Jul 24
•
Céline
1
Hepatitis C, Part 1
How Schering-Plough, Roche, Merck, Vertex, and Janssen turned the tide from a public health epidemic to an 80% cure rate
Jul 18
•
Céline
1
Approvals for cholesterol-lowering and breast cancer, another tau attempt in Alzheimer's, and more
Weekly Readout #14: Week ending July 17, 2026
Jul 17
•
Céline
1
Eli Lilly to Acquire AtaiBeckley
SSRI/SNRI powerhouse bets on neuroplasticity for depression
Jul 17
•
Céline
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
